What's Happening?
Pharmaceutics and Pharmacology, a journal under the Royal Pharmaceutical Society (RPS) and Oxford University Press (OUP), has been relaunched with new editors-in-chief and an updated research focus. Originally
launched in 2022, the journal aims to cover the entire lifespan of pharmaceutical research, from drug discovery to development. The relaunch includes a rebranding and a shift towards interdisciplinary research that improves medicine use. Catherine Sherwin, the new editor-in-chief, emphasizes the journal's focus on advancing safe and effective medicine use through formulation innovation and dose optimization. The journal seeks to bridge the gap between pharmaceutical science and pharmacology, providing a platform for research that translates from laboratory settings to clinical applications.
Why It's Important?
The relaunch of Pharmaceutics and Pharmacology is significant as it addresses the need for a journal that bridges pharmaceutical science and pharmacology. By focusing on translational research, the journal aims to improve how medicines are used, potentially leading to safer and more effective treatments. This approach can benefit researchers and industry professionals by providing insights into drug development and formulation. The journal's open access model ensures that research is freely available, promoting wider dissemination and collaboration. As the journal grows, it may become a key resource for those looking to publish interdisciplinary work that impacts patient care and pharmaceutical practices.
What's Next?
The journal plans to expand its scope by attracting submissions that focus on applied research and development. It aims to differentiate itself from other RPS journals by emphasizing translational research that impacts patient care. The editors are looking to build a strong foundation for the journal, potentially increasing its impact factor and reputation within the scientific community. Researchers and industry professionals are encouraged to submit work that advances the understanding of drug action and formulation. The journal's growth will depend on its ability to attract high-quality research and maintain rigorous peer review standards.
